f Post COVID-19 Pulmonary Fibrosis - The New Pandemic

References

1. KergetB. ÇilG. ArazÖ. AlperF. AkgünM. Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study.Med. Clin. (Barc.)202316012525530
   [Google Scholar]
2. Duong-QuyS. Vo-Pham-MinhT. Tran-XuanQ. Huynh-AnhT. Vo-VanT. Vu-Tran-ThienQ. Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review.Pulm. Ther.202393295
   [Google Scholar]
3. DadhwalR. SharmaM. SuraniS. Restrictive Lung Disease in Patients With Subclinical Coronavirus Infection: Are We Bracing Ourselves for Devastating Sequelae?Cureus2021131e12501
   [Google Scholar]
4. Hama AminB.J. KakamadF.H. AhmedG.S. AhmedS.F. AbdullaB.A. MohammedS.H. Post COVID-19 pulmonary fibrosis; a meta-analysis study.Ann. Med. Surg. (Lond.)202277103590
   [Google Scholar]
5. AdegunsoyeA. BaccileR. BestT.J. ZaksasV. ZhangH. KarnikR. Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States.Lancet Regional Health Americas.2023225100566
   [Google Scholar]
6. Fernández-PlataR Higuera-IglesiasAL Torres-EspíndolaLM Aquino-GálvezA Velázquez CruzR CamarenaÁ Risk of Pulmonary Fibrosis and Persistent Symptoms Post-COVID-19 in a Cohort of Outpatient Health Workers.Viruses.2022; 23; 14(9): 1843.
   [Google Scholar]
7. LeeI. KimJ. YeoY. LeeJ.Y. JeongI. JohJ.S. Prognostic Factors for Pulmonary Fibrosis Following Pneumonia in Patients with COVID-19: A Prospective Study.J. Clin. Med.202211195913
   [Google Scholar]
8. GiacomelliC. PiccarducciR. MarchettiL. RomeiC. MartiniC. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients.Biochem. Pharmacol.2021193114812
   [Google Scholar]
9. SolomonJ.J. HeymanB. KoJ.P. CondosR. LynchD.A. CT of Postacute Lung Complications of COVID-19.Radiology20213012E383E395
   [Google Scholar]
10. ZhaoX. NichollsJ.M. ChenY.G. Severe Acute Respiratory Syndrome-associated Coronavirus Nucleocapsid Protein Interacts with Smad3 and Modulates Transforming Growth Factor-β Signaling.J. Biol. Chem.20082836327280
    [Google Scholar]
11. MylvaganamR.J. BaileyJ.I. SznajderJ.I. SalaM.A. Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection.European Respiratory Review202130162210194
    [Google Scholar]
12. Torres-CastroR. Vasconcello-CastilloL. Alsina-RestoyX. Solis-NavarroL. BurgosF. PuppoH. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis.Pulmonology202127432837
    [Google Scholar]
13. CojocaruE. CojocaruT. PînzariuG.M. VasiliuI. ArmașuI. CojocaruC. Perspectives on Post-COVID-19 Pulmonary Fibrosis Treatment.J. Pers. Med.202414151
    [Google Scholar]
14. KergetB. ÇilG. ArazÖ. AlperF. AkgünM. Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study.Med. Clin. (Barc.).20231601252530
    [Google Scholar]